Paper14531019
Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.
Chiang LC and 4 others. Planta Med, 2003. Cited by 125 papers, by iCite.
Cite this record
ConductScience Library. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Papers, record 14531019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14531019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Antiviral Agents | Major topic |
| Bupleurum | Major topic |
| Hepatitis B virus | Major topic |
| Oleanolic Acid | Major topic |
| Phytotherapy | Major topic |
| Plant Extracts | Major topic |
| Saponins | Major topic |
| Blotting, Western | |
| Carcinoma, Hepatocellular | |
| Cell Line, Tumor | |
| DNA Primers | |
| DNA, Viral | |
| Humans | |
| Polymerase Chain Reaction |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979004 | Antiviral effects of traditional herbal medicine Otsu-Ji-To against human coronavirus OC43, SARS-CoV-2, and its variants: in vitro and in vivo studies. | J Tradit Complement Med | 2026 | https://conductscience.org/library/papers/42979004 | PubMed |
| 42797828 | In Vitro Assessment of Antiviral Activity of Saikosaponin B2 Against Porcine Epidemic Diarrheal Virus. | Viruses | 2026 | https://conductscience.org/library/papers/42797828 | PubMed |
| 42609479 | Traditional Chinese Medicine in Chronic Hepatitis B: Integrating Antiviral Effects and Immune Modulation in the Context of T Cell Exhaustion. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42609479 | PubMed |
| 42228039 | Innovative analysis and future prospects of Bupleuri Radix's pharmacology and toxicity based on the gut-liver axis. | MedScience | 2026 | https://conductscience.org/library/papers/42228039 | PubMed |
| 41971583 | Herbal remedies for hepatic diseases: A review of medicinal herbs in the treatment of liver disorders. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/41971583 | PubMed |
| 40621112 | A web-based pharmacological approach to the mechanism of action of Radix Bupleuri in the treatment of chronic atrophic gastritis. | Cytotechnology | 2025 | https://conductscience.org/library/papers/40621112 | PubMed |
| 40284727 | Preliminary Data on the Antiviral Activity of Helleborus bocconei subsp. intermedius Root Extracts Against Animal Herpesviruses. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284727 | PubMed |
| 39963320 | Role, mechanisms and effects of Radix Bupleuri in anti‑breast cancer (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/39963320 | PubMed |
| 39185081 | Saikosaponins Targeting Programmed Cell Death as Anticancer Agents: Mechanisms and Future Perspectives. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39185081 | PubMed |
| 39124193 | Essential Oil Composition of Bupleurum praealtum and Bupleurum affine: New Natural Constituents. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/39124193 | PubMed |
| 39070799 | Metabolites from traditional Chinese botanical drugs with anti-hepatitis B virus activity - a review. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39070799 | PubMed |
| 38400007 | Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1. | Viruses | 2024 | https://conductscience.org/library/papers/38400007 | PubMed |
| 38313222 | Quantitative analysis of multi-components by single marker method combined with UPLC-PAD fingerprint analysis based on saikosaponin for discrimination of Bupleuri Radix according to geographical origin. | Front Chem | 2023 | https://conductscience.org/library/papers/38313222 | PubMed |
| 38068631 | Latin American Plants against Microorganisms. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/38068631 | PubMed |
| 36547471 | Chemotherapeutic Potential of Saikosaponin D: Experimental Evidence. | J Xenobiot | 2022 | https://conductscience.org/library/papers/36547471 | PubMed |
| 36499380 | Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499380 | PubMed |
| 36034531 | Complete chloroplast genome and phylogenetic analysis of Bupleurum kaoi Liu, Chao, and Chuang, 1977: an endemic species in Taiwan. | Mitochondrial DNA B Resour | 2022 | https://conductscience.org/library/papers/36034531 | PubMed |
| 35630731 | Production of Prosaikogenin F, Prosaikogenin G, Saikogenin F and Saikogenin G by the Recombinant Enzymatic Hydrolysis of Saikosaponin and their Anti-Cancer Effect. | Molecules | 2022 | https://conductscience.org/library/papers/35630731 | PubMed |
| 34122058 | Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34122058 | PubMed |
| 33590931 | Medicinal plants: Treasure for antiviral drug discovery. | Phytother Res | 2021 | https://conductscience.org/library/papers/33590931 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CASP7 | 840 | PubTator's text mining | https://conductscience.org/library/genes/840 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14531019
GET https://conductscience.org/api/papers/v1/14531019/cited_by?page=2